Zakharova said the sanctions are part of a campaign whereby the U.S. and the EU divert the attention of their population from their own internal problems.Full Story
The new pressure measures are aimed at putting pressure on Russia in the framework of the Navalny case.Full Story
The Richmond Laboratories' production will enable this South American nation to supply its domestic market and distribute doses to other countries.
The reaction comes as the EU decided to expand punitive measures against Russia over opposition activist Alexei Navalny's jailing.
The European sanctions constitute a form of pressure exerted in connection with a court case that was prosecuted under Russian law.
Over 3,000 Argentine volunteers took part in the third phase of Sinopharm vaccine clinical trials.
Russia has already signed contracts with 15 companies from ten nations to produce around 1.4 billion doses, which would immunize 700 million people.
Russia will provide this South American country with one million COVID-19 vaccines.
President Putin called on the parties to maintain a "patriotic cohesion" in the face of possible attempts at foreign influence in domestic political processes.
If the Russian or any other vaccine is proven safe and effective, it can be used in any European Union country.
On February 22, EU Foreign Ministers will meet to discuss imposing new sanctions on Russia over the protests last week in support of opposition politician Alekséi Navalny.